Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Jajodia

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|May 7, 2014
Research Highlights: highlights from the latest articles focusing on a new gene set for better drug response prediction of epilepsy patientsRuchi Baghel, Ajay Jajodia, Sandeep Grover, et al.
Nature Communications|February 28, 2020
Candidate silencer elements for the human and mouse genomesNaresh Doni Jayavelu, Ajay Jajodia, Arpit Mishra, et al.
Biomed Research International|May 27, 2014
Gender specific association of RAS gene polymorphism with essential hypertension: a case-control studyKh Dhanachandra Singh, Ajay Jajodia, Harpreet Kaur, et al.
Pharmacogenomics|October 24, 2014
Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project dataHarpreet Kaur, Ajay Jajodia, Sandeep Grover, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 12, 2014
Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illnessHarpreet Kaur, Ajay Jajodia, Sandeep Grover, et al.
Genomics|February 14, 2013
Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patientsMeenal Gupta, Nagaraj S Moily, Harpreet Kaur, et al.
Plos One|July 16, 2014
Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patientsHarpreet Kaur, Ajay Jajodia, Sandeep Grover, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 19, 2012
Genetic studies indicate a potential target 5-HTR(3B) for drug therapy in schizophrenia patientsMeenal Gupta, Sanjeev Jain, Nagaraj S Moily, et al.
Frontiers in Immunology|July 1, 2024
Identification of functional enhancer variants associated with type I diabetes in CD4+ T cellsArpit Mishra, Ajay Jajodia, Eryn Weston, et al.
CNS Neuroscience & Therapeutics|June 2, 2016
Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug LevelsRuchi Baghel, Sandeep Grover, Harpreet Kaur, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|May 7, 2014
Research Highlights: highlights from the latest articles focusing on a new gene set for better drug response prediction of epilepsy patientsRuchi Baghel, Ajay Jajodia, Sandeep Grover, et al.
Nature Communications|February 28, 2020
Candidate silencer elements for the human and mouse genomesNaresh Doni Jayavelu, Ajay Jajodia, Arpit Mishra, et al.
Biomed Research International|May 27, 2014
Gender specific association of RAS gene polymorphism with essential hypertension: a case-control studyKh Dhanachandra Singh, Ajay Jajodia, Harpreet Kaur, et al.
Pharmacogenomics|October 24, 2014
Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project dataHarpreet Kaur, Ajay Jajodia, Sandeep Grover, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 12, 2014
Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illnessHarpreet Kaur, Ajay Jajodia, Sandeep Grover, et al.
Genomics|February 14, 2013
Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patientsMeenal Gupta, Nagaraj S Moily, Harpreet Kaur, et al.
Plos One|July 16, 2014
Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patientsHarpreet Kaur, Ajay Jajodia, Sandeep Grover, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 19, 2012
Genetic studies indicate a potential target 5-HTR(3B) for drug therapy in schizophrenia patientsMeenal Gupta, Sanjeev Jain, Nagaraj S Moily, et al.
Frontiers in Immunology|July 1, 2024
Identification of functional enhancer variants associated with type I diabetes in CD4+ T cellsArpit Mishra, Ajay Jajodia, Eryn Weston, et al.
CNS Neuroscience & Therapeutics|June 2, 2016
Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug LevelsRuchi Baghel, Sandeep Grover, Harpreet Kaur, et al.
Pageof 2